82 Einträge | 1, 2, 3, 4, 5 › » |
Seite 1 / 5
![]() |
Activity of T-DM1 in Her2-positive breast cancer brain metastases. |
Bartsch R, Berghoff AS, Vogl U, Rudas M, Bergen E, Dubsky P, Dieckmann K, Pinker K, Bago-Horvath Z, Galid A, Oehler L, Zielinski CC, Gnant M, Steger GG, Preusser M |
Clinical & experimental metastasis. 2015 Aug 25. doi: 10.1007/s10585-015-9740-3 |
PMID: 26303828 |
Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy. |
Promberger R, Dubsky P, Mittlböck M, Ott J, Singer C, Seemann R, Exner R, Panhofer P, Steger G, Bergen E, Gnant M, Jakesz R, Bago-Horvath Z, Rudas M, Bartsch R |
Clinical breast cancer. 2015 Jun 18. pii: S1526-8209(15)00123-8. doi: 10.1016/j.clbc.2015.06.007 |
PMID: 26195436 |
AF1q is a novel TCF7 co-factor which activates CD44 and promotes breast cancer metastasis. |
Park J, Schlederer M, Schreiber M, Ice R, Merkel O, Bilban M, Hofbauer S, Kim S, Addison J, Zou J, Ji C, Bunting ST, Wang Z, Shoham M, Huang G, Bago-Horvath Z, Gibson LF, Rojanasakul Y, Remick S, Ivanov A, Pugacheva E, Bunting KD, Moriggl R, Kenner L, Tse W |
Oncotarget. 2015 Jun 7. pii: 4136 |
PMID: 26079538 |
Multiparametric MR Imaging with High-Resolution Dynamic Contrast-enhanced and Diffusion-weighted Imaging at 7 T Improves the Assessment of Breast Tumors: A Feasibility Study. |
Pinker K, Baltzer P, Bogner W, Leithner D, Trattnig S, Zaric O, Dubsky P, Bago-Horvath Z, Rudas M, Gruber S, Weber M, Helbich TH |
Radiology. 2015 Mar 4. doi: 10.1148/radiol.15141905 |
PMID: 25751227 |
Epigallocatechin gallate, ellagic acid, and rosmarinic acid perturb dNTP pools and inhibit de novo DNA synthesis and proliferation of human HL-60 promyelocytic leukemia cells: Synergism with arabinofuranosylcytosine. |
Saiko P, Steinmann MT, Schuster H, Graser G, Bressler S, Giessrigl B, Lackner A, Grusch M, Krupitza G, Bago-Horvath Z, Jaeger W, Fritzer-Szekeres M, Szekeres T |
Phytomedicine : international journal of phytotherapy and phytopharmacology. 2014 Dec 3. pii: S0944-7113(14)00398-5. doi: 10.1016/j.phymed.2014.11.017 |
PMID: 25636891 |
Histopathological characterization of ulcerated breast cancer and comparison to their non-ulcerated counterparts. |
Staudigl C, Bartova M, Salama M, Dzagnidze G, Bago-Horvath Z, Pohlodek K, Singer CF, Tea MK |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2014 Dec 28. doi: 10.1007/s13277-014-2977-7 |
PMID: 25544709 |
Bilateral diffusion-weighted MR imaging of breast tumors with submillimeter resolution using readout-segmented echo-planar imaging at 7 T. |
Bogner W, Pinker K, Zaric O, Baltzer P, Minarikova L, Porter D, Bago-Horvath Z, Dubsky P, Helbich TH, Trattnig S, Gruber S |
Radiology. 2014 Oct 23. doi: 10.1148/radiol.14132340 |
PMID: 25341078 |
Quantitative apparent diffusion coefficient as a noninvasive imaging biomarker for the differentiation of invasive breast cancer and ductal carcinoma in situ. |
Bickel H, Pinker-Domenig K, Bogner W, Spick C, Bagó-Horváth Z, Weber M, Helbich T, Baltzer P |
Investigative radiology. 2015 Jan 7. doi: 10.1097/RLI.0000000000000104 |
PMID: 25333308 |
Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients. |
Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG, Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant M, Fitzal F, Zielinski CC, Birner P |
Breast (Edinburgh, Scotland). 2014 Jul 10. pii: S0960-9776(14)00124-6. doi: 10.1016/j.breast.2014.06.011 |
PMID: 25017122 |
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer. |
Exner R, Bago-Horvath Z, Bartsch R, Mittlboeck M, Retèl VP, Fitzal F, Rudas M, Singer C, Pfeiler G, Gnant M, Jakesz R, Dubsky P |
British journal of cancer. 2014 Jul 8. pii: bjc2014339. doi: 10.1038/bjc.2014.339. pmc: PMC4150264 |
PMID: 25003667 |
Improved differentiation of benign and malignant breast tumors with multiparametric 18fluorodeoxyglucose positron emission tomography magnetic resonance imaging: a feasibility study. |
Pinker K, Bogner W, Baltzer P, Karanikas G, Magometschnigg H, Brader P, Gruber S, Bickel H, Dubsky P, Bago-Horvath Z, Bartsch R, Weber M, Trattnig S, Helbich TH |
Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Jul 2. pii: 1078-0432.CCR-13-2810. doi: 10.1158/1078-0432.CCR-13-2810 |
PMID: 24963052 |
Impact of RANK signalling on survival and chemotherapy response in osteosarcoma. |
Bago-Horvath Z, Schmid K, Rössler F, Nagy-Bojarszky K, Funovics P, Sulzbacher I |
Pathology. 2014 Jul 10. doi: 10.1097/PAT.0000000000000116 |
PMID: 24842377 |
The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer. |
Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M |
Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Feb 11. pii: 1078-0432.CCR-13-1845. doi: 10.1158/1078-0432.CCR-13-1845 |
PMID: 24520097 |
Loss of STAT3 in Lymphoma Relaxes NK Cell-Mediated Tumor Surveillance. |
Putz EM, Hoelzl MA, Baeck J, Bago-Horvath Z, Schuster C, Reichholf B, Kern D, Aberger F, Sexl V, Hoelbl-Kovacic A |
Cancers. 2014 Jan 27. pii: cancers6010193. doi: 10.3390/cancers6010193. pmc: PMC3980609 |
PMID: 24473086 |
Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone. |
Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C, Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M, Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu S, Fesl C, Nielsen TO |
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Dec 16. pii: mdt494. doi: 10.1093/annonc/mdt494 |
PMID: 24347518 |
Clinical application of bilateral high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging of the breast at 7 T. |
Pinker K, Bogner W, Baltzer P, Trattnig S, Gruber S, Abeyakoon O, Bernathova M, Zaric O, Dubsky P, Bago-Horvath Z, Weber M, Leithner D, Helbich TH |
European radiology. 2013 Dec 5. doi: 10.1007/s00330-013-3075-8 |
PMID: 24306425 |
Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions. |
Pinker K, Bickel H, Helbich TH, Gruber S, Dubsky P, Pluschnig U, Rudas M, Bago-Horvath Z, Weber M, Trattnig S, Bogner W |
European radiology. 2013 Mar 16. doi: 10.1007/s00330-013-2771-8 |
PMID: 23504036 |
High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer. |
Zagouri F, Bago-Horvath Z, Rössler F, Brandstetter A, Bartsch R, Papadimitriou CA, Dimitrakakis C, Tsigginou A, Papaspyrou I, Giannos A, Dimopoulos MA, Filipits M |
British journal of cancer. 2013 Feb 19. pii: bjc201331. doi: 10.1038/bjc.2013.31. pmc: PMC3619063 |
PMID: 23422757 |
Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer. |
Berghoff AS, Bago-Horvath Z, Dubsky P, Rudas M, Pluschnig U, Wiltschke C, Gnant M, Steger GG, Zielinski CC, Bartsch R |
The breast journal. 2013 Jan 27. doi: 10.1111/tbj.12070 |
PMID: 23350584 |
Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors. |
Berghoff AS, Bago-Horvath Z, Ilhan-Mutlu A, Magerle M, Dieckmann K, Marosi C, Birner P, Widhalm G, Steger GG, Zielinski CC, Bartsch R, Preusser M |
British journal of cancer. 2012 Oct 9. pii: bjc2012440. doi: 10.1038/bjc.2012.440. pmc: PMC3493775 |
PMID: 23047551 |
82 Einträge | 1, 2, 3, 4, 5 › » |
Seite 1 / 5
![]() |